Arthur E. Frankel

Wake Forest University, Winston-Salem, NC, United States 
 2013- University of Texas Southwestern Medical Center, Dallas, TX, United States 
Oncology, Biochemistry, Molecular Biology
"Arthur Frankel"

Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Brenner A, Falchook G, Patel M, et al. (2017) Abstract P6-11-09: Heavily pre-treated breast cancer patients show promising responses in the first in human study of the first-In-class fatty acid synthase (FASN) inhibitor, TVB-2640 in combination with paclitaxel Cancer Research. 77
Bekdash A, Darwish M, Timsah Z, et al. (2015) Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF). Translational Oncology. 8: 347-57
Khoury O, Ghazale N, Stone E, et al. (2015) Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. Journal of Neuro-Oncology. 122: 75-85
Angelot-Delettre F, Roggy A, Frankel AE, et al. (2015) In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent. Haematologica. 100: 223-30
Frolova O, Benito J, Brooks C, et al. (2014) SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia. British Journal of Haematology. 166: 862-74
Tanios R, Bekdash A, Kassab E, et al. (2013) Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leukemia Research. 37: 1565-71
Kassab E, Darwish M, Timsah Z, et al. (2013) Cytotoxicity of anthrax lethal toxin to human acute myeloid leukemia cells is nonapoptotic and dependent on extracellular signal-regulated kinase 1/2 activity. Translational Oncology. 6: 25-32
Yang X, Kessler E, Su LJ, et al. (2013) Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 148-57
Agrawal V, Woo JH, Mauldin JP, et al. (2012) Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells. Anti-Cancer Drugs. 23: 51-64
Flaig TW, Su L, Thorburn A, et al. (2011) DAB389 EGF for the treatment of superficial urothelial cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 255
See more...